Insomnia Pharmacovigilance Study Found No Fall Signal Without Establishing No Fall Risk

Failure to detect a reporting signal is not evidence that an adverse event cannot occur.

What the supplied source reports

The study analyzed 5,447 reports in older adults involving non-benzodiazepine receptor agonists or dual orexin antagonists. It reported differing patterns for ineffective treatment, taste disturbance and dream-related events. None of the studied medicines generated a statistically significant fall signal within that dataset.

Limits of the evidence

Spontaneous reports lack a reliable denominator of all treated people and are influenced by reporting behavior, co-medication and indication. Reporting odds are not incidence rates. These drugs also should not be treated as identical to conventional benzodiazepines simply because their sleep effects overlap.

Implications for expert analysis

For expert review, distinguish absence of disproportional reporting from absence of biological plausibility or patient-level evidence. An individual fall still requires chronology, functional observations and alternative causes. The study addresses patterns in submitted reports, not the probability of falling after a specific dose.

Source and related reading

Source: Publication PMC13008954, read from the supplied PDF. Applications to expert analysis are interpretation.